News
Investor's Business Daily on MSN44m
Ultragenyx, Mereo Hammered For Their Surprise Miss In Brittle Bone DiseaseUltragenyx and Mereo stocks crashed Thursday after their treatment for brittle bone disease missed its mark in a second interim look.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback